NAUTIKA1: A Multicenter Phase II Study with a PD-L1+ Cohort of Patients Receiving Atezolizumab (Atezo) with Low-Dose Stereotactic Body Radiation Therapy (SBRT) as Neoadjuvant Therapy for Resectable Stage IB-III NSCLC
| Autor: | S. Tian, D.E. Kozono, N. Ohri, S. Jolly, B.E. Johnson, J. Chaft, E.M. Toloza, B. Ding, C. Ngiam, K. Schulz, I. Bara, J.M. Lee |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | International Journal of Radiation Oncology*Biology*Physics. 114:e392-e393 |
| ISSN: | 0360-3016 |
| DOI: | 10.1016/j.ijrobp.2022.07.1550 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|